text stringlengths 15 247 |
|---|
Lung, biopsy;
Squamous cell carcinoma |
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10% |
Prostate, biopsy;
No tumor present |
Stomach, endoscopic biopsy;
Chronic active gastritis
with 1) ulcer
2) interstinal metaplasia |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Lung, biopsy;
Adenocarcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 50% |
Colon, colonoscopic biopsy;
Adenocarcinoma, well differentiated |
Prostate, biopsy;
No tumor present |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Adenocarcinoma, poorly differentiated |
Lung, biopsy;
No evidence of malignancy or granuloma |
Lung, biopsy;
1. No evidence of malignancy or granuloma
2. Chronic inflammation with organizing fibrosis |
Prostate, biopsy;
No tumor present |
Prostate, biopsy;
No tumor present |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30% |
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100% |
Stomach, endoscopic biopsy;
Chronic active gastritis |
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Lung, biopsy;
Squamous cell carcinoma |
Stomach, endoscopic biopsy;
Chronic gastritis |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30% |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 25% |
Prostate, biopsy;
No tumor present |
Stomach, endoscopic biopsy;
Chronic active gastritis
with interstinal metaplasia |
Prostate, biopsy;
No tumor present |
Stomach, endoscopic biopsy;
Chronic gastritis
with interstinal metaplasia |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Chronic active gastritis
with interstinal metaplasia |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
1. No evidence of malignancy or granuloma
2. Chronic inflammation with organizing fibrosis |
Stomach, endoscopic biopsy;
Chronic active gastritis |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
Small cell carcinoma |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Lung, biopsy;
No evidence of malignancy or granuloma |
Lung, biopsy;
Squamous cell carcinoma |
Lung, biopsy;
Non-small cell carcinoma, favor adenocarcinoma |
Lung, biopsy;
Non-small cell carcinoma, favor squamous cell carcinoma |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Lung, biopsy;
No evidence of malignancy or granuloma |
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation |
Lung, biopsy;
Adenocarcinoma |
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Stomach, endoscopic biopsy;
Adenocarcinoma, poorly differentiated with poorly cohesive carcinoma component |
Lung, biopsy;
Adenocarcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 5% |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 30%), tumor volume: 10% |
Lung, biopsy;
Squamous cell carcinoma |
Lung, biopsy;
Chronic granulomatous inflammation with necrosis |
Lung, biopsy;
Squamous cell carcinoma |
Stomach, endoscopic biopsy;
Chronic gastritis
with erosion |
Stomach, endoscopic biopsy;
Extranodal marginal zone B cell lymphoma of MALT type |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 70%), tumor volume: 90% |
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated |
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated |
Lung, biopsy;
Metastatic adenocarcinoma, from colon primary |
Colon, colonoscopic biopsy;
Chronic active colitis |
Lung, biopsy;
Adenocarcinoma |
Stomach, endoscopic biopsy;
Chronic active gastritis
with interstinal metaplasia |
Lung, biopsy;
Squamous cell carcinoma |
Lung, biopsy;
Adenocarcinoma |
Lung, biopsy;
Adenocarcinoma |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 2 (Gleason pattern 4: 70%), tumor volume: 90% |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Lung, biopsy;
Adenocarcinoma |
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation |
Stomach, endoscopic biopsy;
Chronic gastritis
with interstinal metaplasia |
Stomach, endoscopic biopsy;
Hyperplastic polyp |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Lung, biopsy;
Squamous cell carcinoma |
Stomach, endoscopic biopsy;
Tubular adenoma with low grade dysplasia |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 70% |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100% |
Stomach, endoscopic biopsy;
Chronic gastritis |
Lung, biopsy;
Small cell carcinoma |
Prostate, biopsy;
Malignant lymphoma |
Stomach, endoscopic biopsy;
Adenocarcinoma, well differentiated |
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10% |
Lung, biopsy;
No evidence of malignancy or granuloma |
Stomach, endoscopic biopsy;
Extranodal marginal zone B cell lymphoma of MALT type |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.